Related Experiment Video
Updated: May 21, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Drug-drug interaction through molecular structure similarity analysis
Santiago Vilar1, Rave Harpaz, Eugenio Uriarte
1Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA. qosanti@yahoo.es
Summary
This study introduces a novel method to predict drug-drug interactions (DDIs) using molecular similarity. The approach identifies potential DDIs, enhancing patient safety and drug development.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Safety
Background:
- Drug-drug interactions (DDIs) cause serious adverse events, posing a significant challenge to patient safety.
- Improved tools for DDI detection are of great interest to regulatory bodies and pharmaceutical companies.
Purpose of the Study:
- To develop a scalable methodology for identifying novel drug-drug interactions (DDIs).
- To leverage molecular structural similarity for predicting potential DDIs.
Main Methods:
- A novel methodology was developed to predict DDIs based on molecular structural similarity to known interacting drugs.
- DrugBank was utilized to collect 9454 established DDIs and compute structural similarity between drug pairs.
Main Results:
- The methodology achieved a sensitivity of 0.68, specificity of 0.96, and precision of 0.26 when validated against the DrugBank database.
- Independent testing using the Micromedex/Drugdex database confirmed the methodology's performance.
Conclusions:
- The proposed method is simple, efficient, and scalable for investigating large numbers of drugs and understanding DDI etiology.
- A database of 58,403 predicted DDIs with structural evidence is provided as an open resource for researchers.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.